Needham & Co downgrades Natus Medical (Nasdaq: BABY) from Buy to Neutral.

Needham analyst says, "We encourage investors to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE